These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4469631)

  • 21. [Monotherapy or polytherapy in epilepsy?].
    Reynolds EH; Shorvon SD; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Jun; 25(2):33-7. PubMed ID: 7339761
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbamazepine update.
    Lancet; 1989 Sep; 2(8663):595-7. PubMed ID: 2570287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities for the in vitro determination of bioavailability. 4. Comparison of the carbamazepine preparations Finlepsin and Tegretol].
    Fürst W; Neubert R; Buchmann E
    Pharmazie; 1984 Mar; 39(3):185-6. PubMed ID: 6728891
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary report on the use of Tegretol sirup in epileptic patients].
    Monaco F; Riccio A; Furlan PM
    Riv Neurol; 1974 Mar; 44(2):123-33. PubMed ID: 4603758
    [No Abstract]   [Full Text] [Related]  

  • 25. Concentration of carbamazepine (Tegretol) in serum and in cerebrospinal fluid in patients with epilepsy.
    Johannessen SI; Strandjord RE
    Epilepsia; 1973 Dec; 14(4):373-9. PubMed ID: 4521093
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction.
    Wright JM; Stokes EF; Sweeney VP
    N Engl J Med; 1982 Nov; 307(21):1325-7. PubMed ID: 7133069
    [No Abstract]   [Full Text] [Related]  

  • 27. The auto-induction of carbamazepine during long-term therapy.
    Pynnönen S; Frey H; Sillanpää M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):247-52. PubMed ID: 7450925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of carbamazepine on serum electrolytes: clinical and theoretical implications.
    Uhde TW; Post RM
    J Clin Psychopharmacol; 1983 Apr; 3(2):103-6. PubMed ID: 6841660
    [No Abstract]   [Full Text] [Related]  

  • 30. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 31. A retrospective study on epileptic patients treated with carbamazepine: interaction between age and co-medication on the drug disposition.
    Kumps A; Mardens Y
    Pharm Acta Helv; 1983; 58(5-6):160-4. PubMed ID: 6867050
    [No Abstract]   [Full Text] [Related]  

  • 32. [Overnight fall in the serum level of carbamazepine (author's transl)].
    Fröscher W; Eichelbaum M; Gugler R; Baur MP
    Nervenarzt; 1979 Mar; 50(3):171-8. PubMed ID: 571537
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with acute carbamazepine poisoning].
    Hruby K; Lenz K; Druml W; Kleinberger G
    Nervenarzt; 1982 Jul; 53(7):414-8. PubMed ID: 7121645
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of nimodipine, a dihydropyridine calcium channel antagonist on the pharmacokinetics of carbamazepine in rhesus monkeys.
    Gupta MC; Garg SK; Das BP; Bhargava VK
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):347-51. PubMed ID: 14723323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
    Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
    Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and Pharmacolinetics of Carbamazepine.
    Morselli PL; Frigerio A
    Drug Metab Rev; 1975; 4(1):97-113. PubMed ID: 812689
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacokinetics of carbamazepine in plasma and saliva of man.
    Pynnönen S
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):465-71. PubMed ID: 579557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic evaluation of anticonvulsants prior to efficacy testing exemplified by carbamazepine in epileptic monkey model.
    Lockard JS; Levy RH; Uhlir V; Farquhar JA
    Epilepsia; 1974 Sep; 15(3):351-59. PubMed ID: 4212234
    [No Abstract]   [Full Text] [Related]  

  • 40. Catastrophic neurologic signs due to drug interaction: Tegretol and Darvon.
    Oles KS; Mirza W; Penry JK
    Surg Neurol; 1989 Aug; 32(2):144-51. PubMed ID: 2749458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.